EnBiotix: Polyphor to Inform about the Financing of its Merger Partner EnBiotix
Polyphor AG and EnBiotix Inc. announced that EnBiotix has completed a convertible debenture raise of USD 11 million to finance its future operations.
Read full article »
EnBiotix is a Massachusetts-based biotechnology firm that develops and commercializes therapies for the treatment of chronic respiratory disorders.
Read more